XML 23 R7.htm IDEA: XBRL DOCUMENT v3.22.4
Statements of changes in shareholders' equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Ordinary shares
Additional paid-in capital
Additional paid-in capital
Cumulative Effect, Period of Adoption, Adjustment
Accumulated other comprehensive income (loss)
Retained earnings (accumulated deficit)
Retained earnings (accumulated deficit)
Cumulative Effect, Period of Adoption, Adjustment
Beginning balance (in shares) at Dec. 31, 2019     99,528,435          
Beginning balance at Dec. 31, 2019 $ 217,790     $ 871,442   $ (2,767) $ (650,885)  
Share-based compensation 75,721     75,721        
Exercise of options (in shares)     2,739,150          
Exercise of options 28,428     28,428        
Issuance of shares in connection with employee stock purchase plan (in shares)     66,691          
Issuance of shares in connection with employee stock purchase plan 3,370     3,370        
Conversion feature of convertible note, net 132,474     132,474        
Other comprehensive income (loss), net of tax expense (1,065)         (1,065)    
Net income (loss) 19,808           19,808  
Ending balance (in shares) at Dec. 31, 2020     102,334,276          
Ending balance at Dec. 31, 2020 $ 476,526 $ (128,972)   1,111,435 $ (132,474) (3,832) (631,077) $ 3,502
Accounting Standards Update [Extensible List] Accounting Standards Update 2020-06 [Member]              
Share-based compensation $ 94,900     94,900        
Exercise of options (in shares)     1,585,617          
Exercise of options 21,182     21,182        
Issuance of shares in connection with employee stock purchase plan (in shares)     51,370          
Issuance of shares in connection with employee stock purchase plan 4,546     4,546        
Other comprehensive income (loss), net of tax expense 663         663    
Net income (loss) (58,351)           (58,351)  
Ending balance (in shares) at Dec. 31, 2021     103,971,263          
Ending balance at Dec. 31, 2021 410,494     1,099,589   (3,169) (685,926)  
Share-based compensation $ 106,955     106,955        
Exercise of options (in shares) 474,116   991,884          
Exercise of options $ 10,295     10,295        
Issuance of shares in connection with employee stock purchase plan (in shares)     86,264          
Issuance of shares in connection with employee stock purchase plan 5,224     5,224        
Other comprehensive income (loss), net of tax expense 736         736    
Net income (loss) (92,534)           (92,534)  
Ending balance (in shares) at Dec. 31, 2022     105,049,411          
Ending balance at Dec. 31, 2022 $ 441,170     $ 1,222,063   $ (2,433) $ (778,460)